RCKT logo

Rocket Pharmaceuticals (RCKT) Free Cash Flow

Annual FCF

-$215.59 M
-$4.20 M-1.99%

December 1, 2024


Summary


Performance

RCKT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

Quarterly FCF

-$47.25 M
+$6.44 M+11.99%

December 1, 2024


Summary


Performance

RCKT Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

TTM FCF

-$215.59 M
-$13.27 M-6.56%

December 1, 2024


Summary


Performance

RCKT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

RCKT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.0%0.0%0.0%
3 y3 years-67.3%+23.6%+8.9%
5 y5 years-145.2%+23.6%+8.9%

RCKT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-67.3%at low-43.3%+23.6%-67.3%+8.9%
5 y5-year-145.2%at low-123.1%+23.6%-145.2%+8.9%
alltimeall time-3239.8%at low-2447.2%+23.6%<-9999.0%+8.9%

Rocket Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-$215.59 M(+2.0%)
-$47.25 M(-12.0%)
-$215.59 M(+6.6%)
Sep 2024
-
-$53.69 M(-3.7%)
-$202.32 M(-3.9%)
Jun 2024
-
-$55.75 M(-5.3%)
-$210.43 M(+0.4%)
Mar 2024
-
-$58.89 M(+73.3%)
-$209.70 M(-0.8%)
Dec 2023
-$211.39 M(+13.2%)
-$33.99 M(-45.0%)
-$211.39 M(-10.7%)
Sep 2023
-
-$61.80 M(+12.3%)
-$236.69 M(+8.0%)
Jun 2023
-
-$55.02 M(-9.2%)
-$219.25 M(+6.3%)
Mar 2023
-
-$60.58 M(+2.2%)
-$206.16 M(+10.4%)
Dec 2022
-$186.76 M(+44.9%)
-$59.28 M(+33.6%)
-$186.76 M(+16.4%)
Sep 2022
-
-$44.36 M(+5.8%)
-$160.46 M(+8.9%)
Jun 2022
-
-$41.94 M(+1.8%)
-$147.35 M(+1.3%)
Mar 2022
-
-$41.18 M(+24.8%)
-$145.44 M(+12.9%)
Dec 2021
-$128.88 M(+24.3%)
-$32.98 M(+5.5%)
-$128.88 M(+4.0%)
Sep 2021
-
-$31.25 M(-21.9%)
-$123.92 M(+8.8%)
Jun 2021
-
-$40.03 M(+62.7%)
-$113.85 M(+13.6%)
Mar 2021
-
-$24.61 M(-12.2%)
-$100.24 M(-3.3%)
Dec 2020
-$103.70 M(+17.9%)
-$28.03 M(+32.3%)
-$103.70 M(-0.9%)
Sep 2020
-
-$21.18 M(-19.8%)
-$104.66 M(+3.6%)
Jun 2020
-
-$26.42 M(-5.9%)
-$101.04 M(+1.8%)
Mar 2020
-
-$28.07 M(-3.2%)
-$99.27 M(+12.9%)
Dec 2019
-$87.93 M
-$28.99 M(+65.1%)
-$87.93 M(+9.0%)
Sep 2019
-
-$17.56 M(-28.8%)
-$80.64 M(+7.3%)
Jun 2019
-
-$24.65 M(+47.3%)
-$75.17 M(+24.5%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$16.74 M(-22.9%)
-$60.37 M(+9.3%)
Dec 2018
-$55.24 M(+111.0%)
-$21.70 M(+79.5%)
-$55.24 M(+12.7%)
Sep 2018
-
-$12.09 M(+22.8%)
-$49.02 M(+19.5%)
Jun 2018
-
-$9.85 M(-15.2%)
-$41.03 M(+20.9%)
Mar 2018
-
-$11.61 M(-25.0%)
-$33.94 M(+29.6%)
Dec 2017
-$26.18 M(-30.6%)
-$15.48 M(+278.0%)
-$26.18 M(+19.1%)
Sep 2017
-
-$4.09 M(+48.7%)
-$21.98 M(-19.0%)
Jun 2017
-
-$2.75 M(-28.5%)
-$27.13 M(-16.8%)
Mar 2017
-
-$3.85 M(-65.8%)
-$32.60 M(-13.7%)
Dec 2016
-$37.75 M(+111.8%)
-$11.28 M(+22.1%)
-$37.75 M(+12.3%)
Sep 2016
-
-$9.24 M(+12.4%)
-$33.60 M(+16.0%)
Jun 2016
-
-$8.22 M(-8.7%)
-$28.98 M(+16.7%)
Mar 2016
-
-$9.01 M(+26.3%)
-$24.84 M(+39.3%)
Dec 2015
-$17.83 M(+83.0%)
-$7.13 M(+54.6%)
-$17.83 M(+30.2%)
Sep 2015
-
-$4.62 M(+12.9%)
-$13.69 M(+14.9%)
Jun 2015
-
-$4.09 M(+105.1%)
-$11.91 M(+20.5%)
Mar 2015
-
-$1.99 M(-33.4%)
-$9.88 M(+1.4%)
Dec 2014
-$9.74 M(+50.9%)
-$2.99 M(+5.5%)
-$9.74 M(+44.4%)
Sep 2014
-
-$2.84 M(+37.9%)
-$6.75 M(+72.5%)
Jun 2014
-
-$2.06 M(+10.9%)
-$3.91 M(+110.9%)
Mar 2014
-
-$1.85 M
-$1.85 M
Dec 2013
-$6.46 M(-6.9%)
-
-
Dec 2012
-$6.94 M
-
-

FAQ

  • What is Rocket Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals annual FCF year-on-year change?
  • What is Rocket Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals quarterly FCF year-on-year change?
  • What is Rocket Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals TTM FCF year-on-year change?

What is Rocket Pharmaceuticals annual free cash flow?

The current annual FCF of RCKT is -$215.59 M

What is the all time high annual FCF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high annual free cash flow is -$6.46 M

What is Rocket Pharmaceuticals annual FCF year-on-year change?

Over the past year, RCKT annual free cash flow has changed by -$4.20 M (-1.99%)

What is Rocket Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of RCKT is -$47.25 M

What is the all time high quarterly FCF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high quarterly free cash flow is -$1.85 M

What is Rocket Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, RCKT quarterly free cash flow has changed by $0.00 (0.00%)

What is Rocket Pharmaceuticals TTM free cash flow?

The current TTM FCF of RCKT is -$215.59 M

What is the all time high TTM FCF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high TTM free cash flow is -$1.85 M

What is Rocket Pharmaceuticals TTM FCF year-on-year change?

Over the past year, RCKT TTM free cash flow has changed by $0.00 (0.00%)